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PENILAIAN TERHADAP PELBAGAI PROGRAM PENDOKKAN 
MOLEKUL DALAM MERAMAL 
AKTIVITI PERENCAT NEURAMINIDASE 
 
ABSTRAK 
Kajian ini dijalankan untuk menilai skor dan kedudukan program pendokkan 
molekul; AutoDock 3.0.5 (AD3), AutoDock 4.2 (AD4) dan AutoDock Vina 
(ADVina) dalam meramal aktiviti perencat neuraminidase dari NCI diversiti set II 
(DSII) dan untuk membandingkan skor kedudukan ligan dengan program Genetic 
Optimization Ligand Docking (GOLD) yang berfungsi sebagai ukuran kedudukan. 
Kemudian, ramalan ini dibandingkan dengan NA enzim assay. Terdapat dua jenis 
protein yang digunakan dalam kajian ini iaitu; set pertama adalah terhadap protein 
kekal dan set kedua adalah terhadap pilihan asid amino yang fleksibel pada protein. 
Pemeriksaan maya protein NA kekal telah dijalankan terhadap AD3, AD4 dan 
ADVina, manakala NA dengan asid amino yang fleksibel telah dijalankan hanya 
terhadap AD4 dan ADVina. Ini disebabkan oleh ketiadaan fungsi asid amino yang 
fleksibel dalam program AD3. Seterusnya, 15 kompaun teratas dari setiap set disiasat 
dengan aktiviti enzim assay NA untuk mengetahui tingkah laku aktivitinya. Pada 
masa yang sama, pendokkan molekul dengan program GOLD terhadap 15 sebatian 
teratas dari setiap set telah dijalankan untuk menganalisis status hubungannya. Hasil 
menunjukkan protein NA kekal menggunakan program AD4 menunjukkan 
keputusan aktiviti assay 4 daripada 15 sebatian yang mempunyai lebih daripada 50% 
perencatan (kompaun 37, 45, 49 dan 51). Protein NA kekal bagi ADVina dan AD3 
memberikan dua (kompaun 30, dan 31) dan tiga kompaun (kompaun 5, 8, 16) 
xx 
 
masing-masing lebih daripada 50% perencatan. Pendokkan molekul dengan asid 
amino NA yang fleksibel oleh program ADVina menghasilkan 2 kompaun lebih 
daripada perencatan 50% (kompaun 20, dan 31) manakala program AD4 tidak 
berjaya menghasilkan kompaun lebih 50% tahap perencatan. Ligan yang 
menghasilkan lebih 50% aktiviti perencatan didapati dari set program pendokkan 
molekul yang berbeza. Penemuan ini melambangkan bahawa setiap program 
pendokkan molekul menangkap ligan secara esklusif. Walau bagaimanapun, 
berdasarkan keputusan kajian, tiada bukti menunjukkan skafold yang eksklusif 
ditangkap oleh program dok yang berbeza. Oleh itu, tiada signifikasi yang jelas ke 
atas ligan kedudukan teratas dengan perencatan aktiviti lebih daripada 50%. 
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EVALUATION OF VARIOUS AUTODOCK MOLECULAR DOCKING 
PROGRAMMES IN PREDICTING THE  
NEURAMINIDASE INHIBITORY ACTIVITY 
 
ABSTRACT 
This study was done to evaluate the scoring and ranking of molecular docking 
programmes; AutoDock 3.0.5 (AD3), AutoDock 4.2 (AD4) and AutoDock Vina 
(ADVina) in predicting the inhibitory activity of neuraminidase inhibitor taken from 
NCI Diversity set II (DSII) and to compare those ranking and scoring with that of 
Genetic Optimization Ligand Docking (GOLD), as the gold standard for ranking. 
Then, validate this prediction with NA enzyme assay. There were two types of 
protein used; first set was against rigid protein and second set was against specified 
flexible residues of protein. Virtual screening of rigid NA protein was run against 
AD3, AD4 and ADVina, whilst flexible side chain of NA was run only against AD4 
and ADVina. This was due to unavailable flexible side chain function in AD3 
manual programme. Top 15 compounds from each set were further investigated with 
NA enzyme activity assays for its activity behaviour. Simultaneously, docking 
simulations with GOLD against top 15 compounds from each set were done to 
analyse its correlation status. The result showed screening of rigid NA protein using 
AD4 gave promising assay activity of 4 out of 15 compounds which have more than 
50% inhibition (compound 37, 45, 49 and 51). Rigid NA protein against ADVina and 
AD3 gave two (compound 30, and 31) and three compounds (compound 5, 8, 16) 
with over 50% inhibition respectively. Docking with flexible residues of NA with 
ADVina resulted in 2 compounds with more than 50% inhibition (compound 20, and 
31) and AD4 with no compound over 50% inhibition level. Compounds with more 
xxii 
 
than 50% inhibition activity were captured from different docking sets. Findings 
symbolized that each docking set capture ligand exclusively. However, based on the 
results, it showed no exclusive scaffold captured by distinguished docking software. 
Hence, there was no significant difference on top 15 selected compound constituents 
with more than 50% activity.  
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CHAPTER ONE 
INTRODUCTION 
1.0 Problem of statement 
 Molecular docking is one of the most popular molecular modelling 
techniques. It starts with a simple theory of ‘lock and key’ model, and yet the ideas 
are expanding paralleled with computer technologies. Thousands of docking 
softwares can be found on the internet; either for free or with licence required 
(Kitchen et al., 2004). Each docking program has its own advantage over the others 
(Cole et al., 2005, Perola et al., 2004, Bursulaya et al., 2003, Paul and Rognan, 2002, 
Kellenberger et al., 2004). The programs have their own specialties and advantages 
on how to dock compound into the protein with different manipulated searching 
algorithm and force field. 
Predicting how a small molecule binds at the binding site is not an easy task 
although there are many simple docking tools available online. There are many 
problems associated with protein-ligand docking simulation (Cole et al., 2005). 
These include reliability of conformation prediction, the ability of scoring function 
and the capability of searching algorithm to find optimise ligand conformations and 
orientations (Cole et al., 2005, Perola et al., 2004, Leach et al., 2006, Huang et al., 
2006, Warren et al., 2006).  
Explosion of researches in biomolecular x-ray crystallography provides 
continuously the addition of protein and nucleic acid structures in various databases. 
These structures might be the targets for bioactive agents in controlling diseases. 
Using molecular docking, these targets can be ascertained to interact with the 
2 
 
potential therapeutic agents. With the aid of virtual screening and good 
computational power, the docking process can be accelerated and applied to 
thousand compounds in search of potential therapeutic agents (Verdonk et al., 2004, 
Seifert and Lang, 2008). In addition, by screening compound libraries, it may 
increase hit rates in lead discovery in a fast time track. Hence, without doubts, 
molecular docking can help researchers to save money, raw materials as well as time 
consumption (Verdonk et al., 2004).       
As a case study, searching for potential therapeutic agent(s) for 
Neuraminidase (NA) of influenza virus was selected. Previously, successful NA 
inhibitors; zanamivir (ZMR) [Ralenza
TM
] and oseltamivir (OST) [Tamiflu
TM
] (von 
Itzstein et al., 1993, Kim et al., 1997) were discovered from structure based drug 
design (SBDD). However, due to the ability of NA to undergo mutation; novel 
inhibitors are needed continuously to fight against the virus (D’Ursi et al., 2009, 
García-Sosa et al., 2008).      
The aim of this research is thus to evaluate the scoring and ranking of 
molecular docking programmes; AutoDock 3 (AD3), AutoDock 4 (AD4), AutoDock 
Vina (ADVina) in predicting the inhibitory activity of neuraminidase inhibitor and to 
compare those ranking and scoring with that of Genetic Optimization Ligand 
Docking (GOLD), the gold standard for ranking. Subsequently, these predictions 
were validated with neuraminidase enzyme assay. The test compounds for docking 
were taken from NCI Diversity Set II (DSII) library which comprises 1364 
compounds. The ranking was based according to their free energy of binding (FEB) 
between ligand and receptor.   
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1.1 Molecular Modelling 
Molecular modelling briefly can be interpreted as idealised description of a 
system or process, usually by using mathematical language devised to facilitate 
calculations and predictions of respective molecule state (Leach and Schomburg, 
1996). The collaboration of chemistry, biology, and physics with the aid of 
mathematical interpretation has brought up a new dimension toward human 
achievement in explaining the ‘unseen’ properties and mechanisms of molecular 
stage reaction. Previously, molecular modelling research is restricted to only a small 
number of scientists due to lack of computer hardware and software access. 
Nowadays, computer workstations are growing and can be purchased in relatively 
cheaper price than before. Plus, molecular modelling can now be performed in any 
laboratory and classroom sake. 
Before the twentieth century, human only obtained medicines in the form of 
herbs and potions (Silverman, 2004). The isolation of active compounds in herbs was 
only done in the late nineteenths century which lead to the revolutionary of medicinal 
chemistry (Patrick, 2009, Silverman, 2004). Explosion of drug discovery has resulted 
in increasing billion of dollar pharmaceutical companies (Coupez and Lewis, 2006, 
Macarron et al., 2011). However, searching for suitable drug against specific disease 
is such a lengthy process without the aid from Computer Aided Drug Design 
(CADD) (Murray et al., 1999, Klebe, 2006). Traditional way of drug design was 
costly with time consuming and wasted in used of raw materials. Alternatively, the 
introduction of virtual screening (VS) before experimental high-throughput screening 
(HTS) (Macarron et al., 2011, Hertzberg and Pope, 2000) helps to filter for leads 
from library of thousand compounds virtually and consequently reduced the assay 
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volume (Ghosh et al., 2006, Patrick, 2009). In addition, the combination between 
structure based drug design and high speed clusters computer has allowed larger 
screening of libraries of compounds against pharmaceutical-relevant targets 
(Cosconati et al., 2010b, Beuscher Iv and Olson, 2007). Nowadays, virtual screening 
is a routine method when it comes to screen biologically active compounds in the 
nick of time. Screening can easily be done against a library of compounds such as 
from NCI repository and also large database like Directory of Universal Decoy 
(DUD) database (Huang et al., 2006).    
Various operations carried out in molecular modelling involve the use of 
programs or algorithm which are able to calculate the structure and property of 
investigation’s molecule. For example, it is possible to calculate the energy of a 
particular arrangement of atoms (conformations), modification of structure to create 
a minimum energy and calculation of varieties of properties (heat of formation, 
charge, dipole moment. Basically, there are two categories for computational 
method; molecular mechanics (MM) and quantum mechanics (QM) which are used 
to calculate structure and property data of molecule in question. QM considers the 
interaction between electron and nuclei to calculate the properties of the molecule. 
While, MM treats atom as a whole, without consideration of electron and nuclei 
interaction. Methods of calculation chosen depends on the type of calculation needs 
to be done as well as molecule size. QM calculation is limited to calculate molecule 
containing ten to hundreds of atoms while MM calculation can calculate molecule 
with thousands of atoms. Hence, at the present time, only MM approach is suitable 
for calculation of protein interaction with consideration of computer capability.     
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1.1.1 Molecular Mechanics (MM) 
In MM, a molecule is treated as a series of atoms (spheres) connected by 
bonds (springs). Equations are used which follow the laws of classical physics and 
apply them to nuclei without consideration of electrons. Then, equations derived 
from classical mechanics are used to calculate the different interactions and energies 
(force filed) resulting from bond stretching, angle bending, torsional energies and 
non-bonded interactions. Such calculations require parameters or data’s being stored 
in tables within the programme and which describe interactions between different 
sets of atoms. MM is useful for the calculations of energy minimization, identifying 
stable conformations, generating various conformations, energy calculations for 
specific conformations and studying of molecular motions (Patrick, 2009).   
One of the vital calculations by MM is energy minimization of 3D structures. 
Once after the structure is built or downloaded directly from any source, energy 
minimizations must be carried out to avoid unfavourable bond lengths, bond angles 
or torsion angles (Kitchen et al., 2004, Leach and Schomburg, 1996). The energy of 
the starting structure is calculated to see whether it is stable or not. If the structure is 
unstable, even a slight alteration in bond length or bond angle will have a large effect 
on the overall energy of the molecule which will result in large energy difference 
(ΔE). Hence, modification of bond lengths, bond angles, torsion angles and non-
bonded interactions are necessary until a stable conformation is obtained. There are 
various software packages available to calculate the energy minimizations such as 
Hyperchem, Discovery Studio, Chem 3D and etc. (Patrick, 2009). In this study, 
Hyperchem package 6.01 for windows was used for minimization purposes.         
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1.1.2 Structure Based Drug Design (SBDD) 
Structure based drug design was initiated based on the availability of reliable 
drug target structures from experimental sources such as X-ray crystallography and 
NMR spectroscopy (Leach and Schomburg, 1996, Hetényi and van der Spoel, 2002). 
Screening of ligands by structure based method is proven to increase the likelihood 
of finding compatible ligand from among many structures in the database (Shoichet, 
2004).  
There are many successful screening of genuinely novel compounds such as 
inhibitors of protein kinases, HIV-protease, carbonic anhydrase, neuraminidase 
(NA), and thrombin (Bortolato et al., 2013, Rizzo et al., 2000). SBDD has been 
applied to NA system and resulted in the discovery of active inhibitors towards 
influenza virus A. NA has a conserved catalytic site with its natural inhibitor (sialic 
acid (Neu5Ac)). The structural information’s of NA has been utilized to mimic the 
transition state of Neu5Ac which in the form of DANA (Neu5Ac2en) to produce new 
inhibitors (OST and ZMR) with higher binding affinity towards receptor (von 
Itzstein et al., 1993).       
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1.1.3 Molecular Docking 
There are abundance numbers of docking programmes available on the 
internet and the number is increasing over the years. Examples of frequently used 
docking programmes are AutoDock (Morris et al., 2009), GOLD (Verdonk et al., 
2003), DOCK (Makino and Kuntz, 1997), FlexX (Rarey et al., 1996) , Glide 
(Friesner et al., 2004) and ICM (Abagyan et al., 1994).          
The rule of thumbs when applying molecular docking is to balance between 
the desire for a robust and accurate procedure (Morris et al., 1998). Secondly is to 
balance the desire to keep the computational demands at a reasonable level (Morris et 
al., 1998, Morris et al., 2009). Historically, early approaches to ligand docking is by 
assuming both ligand and protein to be rigid as applied in DOCK program (Kuntz et 
al., 1982). This assumption encounters many limitations in many studied systems 
(Jones et al., 1997, Hetényi and van der Spoel, 2002). Then, the theory evolved with 
significant modification such as enabling the ligand conformational degrees of 
freedom to be explored (Leach et al., 2006). Nowadays, most of docking programs 
treat the ligand as flexible with rigid or slightly flexible receptors (Leach et al., 2006, 
Morris et al., 2009). However, by increasing degrees of flexibility of certain receptor 
might increase the computational complexity and also the cost (Carlson, 2002).     
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1.1.3.1 Evolution of Molecular Docking’s Software 
Original approach of molecular docking comes from the concept of ‘lock and 
key’ of rational drug design. The theory is evolving with time to mimic the actual 
situation of docking hence optimise the results. Currently, most researchers roughly 
class the docking mode into four models (Figure 1.1); 1) lock and key, 2) 
conformation isomerism, 3) induced-fit and 4) conformation selection (Chen, 2015, 
Mukhopadhyay, 2014). However, the precise algorithms used to fit the ‘key’ (ligand) 
into the ‘lock’ (receptor protein) vary across programmes. A user may choose 
different docking modes based on the ability of their computational hardware and the 
character of target protein. Basically, rigid docking refers to the protein and ligand 
being fixed so that bond angles or lengths are not changeable. While, flexible 
docking allows for conformational shifts, changeable bond angles and lengths of 
either receptor or ligand or both at a time. 
 
Figure 1.1: The docking mode roughly divided into  
four types of docking mode (Chen, 2015). 
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Efficient protein-ligand docking can be obtained with aid from two essential 
components, which are ‘sampling’ and ‘scoring’ (Huang and Zou, 2010, Schulz-
Gasch and Stahl, 2004, Kroemer, 2007). Sampling can be divided to two categories 
which are ligand sampling and protein flexibility. Sampling refers to a probability of 
finding a correct orientation of flexible ligand and the proper conformation of the 
receptor molecule (Kroemer, 2007). Ligand sampling indicates orientations of ligand 
around specified binding site while protein flexibility occur when ligand bind to the 
binding site and induce protein conformational changes. More significant changes 
will occur when the side chains of a macromolecule are assigned as flexible (Huang 
and Zou, 2010).   
Figure 1.2 shows basic graphic simulation of sampling and scoring in docking 
with large compound collections. One way of achieving this is via in silico or virtual 
screening (VS) of compound libraries against receptor’s binding site or commonly 
known as SBDD. Screening of compounds against specific binding pocket in a 
variety of positions, conformations, and orientations will results in multiple ‘pose’ 
predictions (Figure 1.2). In order to identify the energetically most favourable ‘pose 
predictions’, each pose is evaluated or ‘scored’ based on its complementarity to the 
target in terms of shape and properties such as electrostatics. A good score for a 
given compound indicates that it is potentially a good binder. This process is 
repeated for all compounds in the libraries which are subsequently rank-ordered by 
their scores or predicted affinities (for example binding energy) (Kroemer, 2007).      
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Figure 1.2: R symbolizes a receptor structure whiles A, B, and C represents small 
molecules to be docked into the receptor (Kroemer, 2007).          
  
Scoring function will determine each molecule’s ranking. Scoring is meant to 
evaluate affinity between a ligand and a protein based on the energy function and 
subsequently to rank the ligands according to the relative binding affinity. Numerous 
scoring functions have been developed and they can be divided into three groups:  1) 
force field based; 2) empirical; and 3) knowledge-based scoring functions (Schulz-
Gasch and Stahl, 2004, Huang and Zou, 2010).    
In this study, four types of docking programmes were used. The softwares 
were chosen are those common tools used among researchers (Chen, 2015) and 
availability in the laboratory:  three AutoDock (AD) programmes from The Scripps 
Research Institute group while GOLD was subscribed from CCDC software Ltd. 
Company (Jones et al., 1997). AD programmes are docking tools released under 
open source licences (GNU General Public Licence and Apache Open Source 
Licence) (Chang et al., 2010, Goodsell et al., 1996, Morris et al., 1998, Morris et al., 
2009). The first AD version was first distributed in the year of 1990 (Goodsell and 
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Olson, 1990), followed by the second version in the year of 1996 (Goodsell et al., 
1996), while the third version was released in 1998 (Morris et al., 1998) and the 
number of user has grown with the latest version of AD4 programme released in 
2007 (Morris et al., 2009, Chen, 2015). Table 1.1 below briefly describes each 
docking programmes used in this experiment. 
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Table 1.1: Comparison between the docking programmes used in the study 
 AD3 AD4 Vina GOLD 
 
 
 
Molecular 
representation 
 
 
 
 
Main program consists of two main 
programs:  
 
 AD performs the docking 
of the ligand to a set of 
grids describing the target 
protein;  
 Autogrid pre-calculates 
these grids. 
 
consists of two main 
programs:  
 
  AD performs the docking of 
the ligand to a set of grids 
describing the target protein;  
  Autogrid pre-calculates 
these grids. 
Does not require choosing 
atom types and pre-
calculating grid maps for 
them.  
 
 Calculates the grids 
internally, for the atom 
types that are needed, and 
it does this virtually 
instantly. 
 
Using Gold Suite program 
which include: 
 
 Hermes visualizer for 
structure and binding site 
preparation, result’s viewing 
and descriptor’s calculation. 
 GoldMine for analysis of post 
results.  
Macromolecule 
flexibility 
(side chain) 
No Yes Yes Yes 
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Continued:- Table 1.1:  Comparison between the docking programmes used in the study 
Atom types  C 
 N 
 O 
 S 
 H 
 X or M 
Expanded set of atom types 
as AD3 included:   
 A (aromatic carbon) 
 C (aliphatic carbon) 
 HD (hydrogen donor) 
 NA (nitrogen acceptor) 
 OA (oxygen acceptor) 
 SA (sulphur acceptor) 
 
Not required to choose 
 Used automatically 
according to X-score 
(Wang et al., 2002) atom 
typing scheme 
 
 
SYBYL atom type (Ash et al., 
1997) 
Example: 
 sp2 oxygen= O.2 
 sp3 oxygen= O.3 
 tetrahedral nitrogen= N.3/N.4 
 planar nitrogen= N.pl3/N.am 
 carboxylate oxygen= O.co2  
 etc. 
Initial 
structure 
 MOL2 
 PDB 
 MOL2 
 PDB 
 MOL2 
 PDB 
 MOL2 
 PDB 
Input files  Ligand –pdbq 
 Macromolecule –pdbqs 
 Ligand –pdbqt 
 Macromolecule –pdbqt 
 Ligand –pdbqt 
 Macromolecule –pdbqt 
 N/A 
Scoring 
function 
 Van der Waals 
 Electrostatic 
 Hydrogen bond 
 Torsional penalty 
 Desolvation 
 
 Van der Waals 
 Electrostatic 
 Hydrogen bond 
 Torsional penalty 
 Desolvation 
 Update in charge based-
desolvation term 
 Improvement in 
directionality of H bond 
 Unbound state model 
 Mostly inspired by X-
score (Wang et al., 2002) 
 Hydrophobic interaction 
  (van der Waals) 
 Hydrogen bond 
 Torsional penalty 
 
 Protein-ligand hydrogen 
bond energy (external H-
bond) 
 Protein-ligand van der Waals 
(vdw) energy (external vdw) 
 Ligand internal vdw energy 
(internal vdw) 
 Ligand torsional strain 
energy (internal torsional) 
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Continued:- Table 1.1:  Comparison between the docking programmes used in the study 
Searching 
algorithm 
 SA (Simulate annealing) 
 LGA (Lamarckian GA)  
 SA 
 LGA   
 Inspired by X-score (Wang 
et al., 2002) with some 
modification  
 GoldScore 
 ChemScore 
 ASP (Astex Statistical 
Potential) 
 CHEMPLP (Piecewise Linear 
Potential (PLP)) 
 User Defined Score 
15 
 
1.2 Influenza Neuraminidase  
1.2.1 The Influenza virus 
One of the darkest moments over mankind history was written in the year of 
1918-1919, where mankind were afflicted with influenza virus disease or better 
known as ‘Spanish’ A(H1N1) influenza virus. The virus swept across the globe and 
infected approximately 25% of the entire population and sacrificed at least 50 million 
human’s lives worldwide (Reid et al., 2003, Lin et al., 2000, Potter, 2001). In the 
following years, the A (H1N1) virus has continued to circulate among humans and 
caused a number of severe outbreaks in the year between 1920s-1950s (Viboud et al., 
2006b, Viboud et al., 2006a). Particularly, an outbreak in the year of 1957, which 
also known as ‘Asian flu’, showed that A(H1N1) had been replaced by a reassorted 
A(H2N2) influenza virus and caused almost 1 million deaths (Shen et al., 2009). In 
1968, the virus had evolved again in the form of H3N2 and it caused what was better 
known as ‘Hong Kong Flu’ pandemic (Viboud et al., 2006b, Viboud et al., 2006a). 
The outbreak caused approximately 1 million deaths. In 1977, an identical A(H1N1) 
virus from 1950s caused the Russian influenza pandemic (Nakajima et al., 1978, 
Horimoto and Kawaoka, 2001). 
Around 1997, H5N1 virus was first isolated from human (Claas et al., 1998, 
Chan, 2002). Highly Pathogenic Avian Influenza (HPAI) H5N1 virus was virulent 
and believed to occur among birds and able to cause high mortality especially in 
domestic poultry. However, transmission of virus from bird to human were recorded 
but human to human transmission is quite rare (Yuen and Wong, 2005). Research 
showed that if transmission between human ‘efficiently’ occur, the effect might be 
exceeding the total death caused by 1918 Spanish flu (Grienke et al., 2012, Santos-
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Preciado et al., 2009). Thus, this fact had raised concern over the possibility of a 
major pandemic among world populations (Horimoto and Kawaoka, 2001, Snacken 
et al., 1999).  
In the year of 2009, World Health Organization (WHO), due to the rapid 
global spread of a strain influenza A (H1N1) virus, has warranted moving the global 
pandemic alert level to phase 6 (WHO, 2010a) as 18366 deaths recorded around the 
world in such short time span. Phase 6 indicated that a global human pandemic of 
this virus isolate was under way (WHO, 2010b, Schnitzler and Schnitzler, 2009, 
CDC, 2010). Malaysia was also not spared as evidence from the confirmation by 
Ministry of Health Malaysia, where 91 death cases reported due to A (H1N1) and 
about 15380 cases for patients with Influenza-like Illness (ILI) symptom as of 17th 
July 2010 (MOH, 2010).  
Since then, unpredictable sporadic spreading of various influenza viruses has 
been recorded up to 2013 (WHO, 2013b). Starting from 2011 to 2012, about 309 
cases of human infected H3N2 virus were reported in the United State of America 
alone.  Meanwhile, in 2013, an outbreak caused by H7N9 virus occurred in China 
with 135 people infected (CDC, 2013b, WHO, 2013a). Fortunately, both strains 
show no sustainability in human to human transmission yet and most of the cases 
were due to long exposure towards pigs (CDC, 2013a, Ke et al., 2013). The 
unforeseen effect of the influenza virus transmission is felt globally each year. 
Therefore, extreme effort is needed to control the spreading of the virus.   
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1.2.2 Structure and characteristics of influenza virus 
Influenza virus, which belongs to orthomyxoviridae family, consists of three 
different strains, types A, B and C. However, most major outbreaks of  influenza are 
due to influenza type A. Type B usually caused milder infections among human 
compared to type A as it mutates slowly over time (Kamali and Holodniy, 2013). 
Meanwhile, type C is the most stable strain compared to both of the strains and not 
relatively common to cause any harm to human being (Whitford, 2005).  
Generally, viral classification (into the three different types) is done based 
upon the matrix and nucleoprotein (NP) antigens (Webster et al., 1992). Influenza A 
virus can be further classified into subtype based on the antigenic properties of its 
surface glycoproteins of haemagglutinin (HA) and neuraminidase (NA), where both 
HA and NA play essential roles for infection (Udommaneethanakit et al., 2009, 
Horimoto and Kawaoka, 2001, Webster et al., 1992, Gamblin and Skehel, 2010, 
Kamali and Holodniy, 2013) to proceed. Currently, they are about 16 serotypes of 
HA (H1-H16) and 9 serotypes of NA (N1-N9) found (Kamali and Holodniy, 2013, 
Shi et al., 2010) giving 144 probabilities of the arrangement combinatorial diversity 
of the possible A/HN subtypes (Metzgar et al., 2010). For HA, the majority of human 
infections were caused by H1 and H3 and in occasional cases caused by H5, H7 and 
H9. NA with types N1, N2 and N9 are currently known circulating in human 
population (Kamali and Holodniy, 2013).  
Typically, virus can be described as protein packages which delivered some 
genetic material to desire host cells. Influenza A virus is a member of 
orthomyxovirus family with negative strand RNA composed of eight unique 
segments (Figure 1.3). The virus is in the form of pleomorphic object, where it exists 
as irregular round bodies. The diameter of the virus is about 80 to 120nm. Eight 
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RNA segments bind to a nucleoprotein (NP) and associated with a polymerase 
complex and are located inside a shell. The shell is formed by the matrix protein and 
surrounded by a lipid membrane (derived from the host cell) embedded with two 
important glycoproteins, haemagglutinin (HA) and neuraminidase (NA) (Whitford, 
2005, Patrick, 2009).  
 
 
Figure 1.3: Schematic representation of influenza virus virion. 
 
For cells to be infected, a single virus particle must possess eight unique RNA 
segments. The segments then encode 10 recognised gene products which are two 
viral polymerase basic subunits (PB1, and PB2), Polymerase A (PA), HA, NP, NA, 
M1 and M2 proteins, NS1 (non-structural 1) and NS2 (non-structural 2) proteins 
(Tan et al., 2015). Basic function for each gene is mentioned as below. HA is 
responsible for virions binding and fusion towards the host cell. While, NA plays a 
role to cleave terminal sialic acid from the host cell and release new virions for 
continuing the spread of the virus. PB1, PB2 and PA are three polymerase proteins 
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associated with RNA polymerase and are responsible for replication and translation 
process (Rodriguez-Frandsen et al., 2015). M1 protein on the other hand, is the most 
abundant protein in the virus virion (Nayak et al., 2004). M2 protein acts as an ion 
channel which serves to control the pH of the virion’s interior (Webster et al., 1992). 
Non-structural protein; NS1 and NS2 functions are postulated to kill the host cells 
responded to the virus infection (Gong et al., 2007). However, specific function of 
NS2 is still unknown (Whitford, 2005, Webster et al., 1992, Nayak et al., 2004).             
 
1.2.3 Neuraminidase: The structure and function 
Neuraminidase (NA) also known as sialidase (EC 3.2.1.18) is one of the 
major surface glycoprotein despite HA of the influenza virus with approximately 
molecular weight of 240kD. The viral enzyme was discovered by Alfred Gottschalk 
and co-workers (Gong et al., 2007, Gubareva et al., 2000). It is known for its role to 
cleave terminal α-ketosidic linkage sialic acid residues (Figure 1.4) which linked to 
glycoproteins, glycolipids and oligosaccharides (terminal carbohydrate unit of upper 
respiratory tract and lung) (Xu et al., 2008, Grienke et al., 2012, Webster et al., 1992, 
Nayak et al., 2004, Colman, 1994) and continuously released final infected progeny 
to infect more cells. This receptor destroying enzyme also facilitates in promoting 
penetrations of virus through human’s epithelium airway (Xu et al., 2008, Grienke et 
al., 2012).  
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Figure 1.4: Sialic acid, N-acetylneuraminic acid, Neu5Ac 
 
NA can be grouped based on antigenicity into 9 different serotypes N1 to N9  
(Kamali and Holodniy, 2013, Colman, 1994). Within the different of NA serotype, 
they are further distinguished by two types of groups; 1) group 1: N1, N4, N5, N8 
and 2) group 2: N2, N3, N6, N7, and N9 (Kamali and Holodniy, 2013, Webster et al., 
1992, Vavricka et al., 2011). Generally, most researchers suggested that the group 
was categorised based on the so-called flexible ‘150- loop’ on NA amino acid where 
group-1 indicates an open form of NA protein while group-2 is in a closed position 
of  sialidase apo form structure (Rudrawar et al., 2010, Russell et al., 2006, von 
Itzstein, 2007). The open form causes the prominent formation of pocket located at 
150-loop sialidase structure (Grienke et al., 2012). 
 General NA structure is composed of four identical subunits forming 
homotetramer of tetramic glycoprotein (Patrick, 2009, Colman, 1994, Grienke et al., 
2012). The tetramer possessed mushroom-like shape which anchored to the viral 
membrane by a single hydrophobic sequence of some 29 amino acids near the stalk 
of N-terminus (Patrick, 2009, Colman, 1994, Grienke et al., 2012), which result in 
the capability of enzyme to be split enzymatically from the surface without loss of 
any antigenic activity (Patrick, 2009). The terminal hydrophobic sequence acts as 
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signal a for transport to the cell membrane and as transmembrane domain (Webster 
et al., 1992). The morphology of NA is basically composed of cytoplasmic domain, 
N-terminus domain and stalk region (Gubareva et al., 2000). The active site is placed 
at the center of each subunit with highly conserved residues (Varghese et al., 1983, 
Gong et al., 2007, Patrick, 2009).  
 
NA structure fits its function. Briefly, other than cleaving terminal α-ketosidic 
linkage, NA also corresponds to the process of cell infection, cell replication, 
catabolism, signal transduction, and delivery of viruses into target cell (Gong et al., 
2007, Magesh et al., 2006). Amino acids in NA catalytic site are highly conserved 
and less mutation occur inside the catalytic site compared to other sites in the 
enzyme. In contrast, chances of mutation in HA to occur is higher than NA which 
prompted most researchers to select NA as a drug target (Webster et al., 1992, von 
Itzstein, 2007) for further manipulation against mutated influenza virus.          
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1.2.4 Neuraminidase active site 
Most of NA possessed common feature of catalytic site with similar 
interacting amino acids (Xu et al., 2008, Gong et al., 2007) (Figure 1.5) (Stoll et al., 
2003) defines the common active site in influenza virus. Basically, the catalytic site 
is divided into 5 sites and denominated subsites as S1-S5. The labelled is in counter 
clockwise model by using the crystal structure of the substrate-based inhibitor 
DANA (Neu5Ac2en) embedded to the active site. DANA (2-Deoxy-2,3-Dehydro-N-
Acetyl-Neuraminic Acid) is a transition-state analog formed of Neu5Ac.  
Site S1 involved three residues in example of ARG118, ARG292 and 
ARG371. The residues provide a positively charged electrostatic and hydrogen 
bonding environment for anionic substituents from the inhibitor, such as carboxylate. 
Site S2 on the other hand consists of GLU119 and GLU227 which provide a 
negatively charged site of the active site. Site S3 contains a small hydrophobic region 
established from the residues of TRP178 and ILE222 near to the polar region of 
ARG152. Meanwhile, site S4 consists of hydrophobic region derived from the 
residues of ILE222, ALA246 and the hydrophobic face of ARG224. This site is not 
occupied by any portion of the Neu5Ac2en inhibitor. Site S5 is a mixed polarity 
region and comprised of the carboxylate of GLU276 (trans conformation) and the 
methyl of ALA246. GLU276 can exist as an alternative gauche conformation with its 
carboxylate ion-paired together with ARG224. When GLU276 is in this pose, its 
methylenes join with ALA246 to create a hydrophobic pocket in S5. Additionally, 
one more important residue in the catalytic site is ASP151 and it is not formally 
defined part in the subsites. While the residue’s carboxylate does not make a direct 
contact with Neu5Ac2en, ASP151 is believed to play an important role in catalysis 
by polarizing the scissile glycosidic linkage (Stoll et al., 2003, Gong et al., 2007). 
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Figure 1.5: Diagram of NA active site with Neu5Ac2en (DANA) inhibitor 
(PDB: 1NNB) showing the general location of sites S1-S5 and important 
nearby residues (Stoll et al., 2003).    
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1.2.5 Mechanism of viral infection 
Haemagglutinin (HA) initiates the viral infection via interactions with cell 
surface receptors which contain sialic- acid group (N-acetyl neuraminic acid 
(Neu5Ac)) (Melidou et al., 2010). The virus binds to -2,3-linked and -2,6-linked 
sialic acid receptors which are found on the surface of cells located deep in the 
epithelium airway (Maldonado et al., 2006, Matrosovich et al., 2004). Once HA is 
attached to the glycans containing the terminal sialic acid on the surface of the 
epithelial cells (at respiratory tract), it then allows the penetration of the virus into the 
host cell, by endocytosis where fusion of the viral and endosomal membranes allows 
the release of viral RNA. The RNA then will be transferred to the nucleus, where the 
viral genome is transcribed and amplified before translation of mRNA in the 
cytoplasm. Then, the new viral genome strains will be packaged with structural 
proteins in ribonucleoprotein particle (RNP). Afterwards, NA will cleave the 
terminal linkage of sialic acid receptors which result in the release of the progeny 
virions (viral genome) from the infected host cells (Whitford, 2005, Wang et al., 
2010, Hu, 2010). Figure 1.6 shows the life cycle of the influenza A virus and the 
pathway of viral entry and exit from host cells. 
